Literature DB >> 11566187

Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload.

V Owino1, S Y Yang, G Goldspink.   

Abstract

The response of insulin-like growth factor-1 (IGF-1) signalling and the capacity of skeletal muscle to adapt to mechanical overload was studied using synergistic muscle ablation. Overload of the plantaris and soleus resulted in marked hypertrophy and activation of satellite cells (as indicated by MyoD expression), particularly in young rats. Two muscle IGF-1 splice variants were measured and found to be differentially regulated at the RNA level. The significant changes associated with the inability of the older muscles to respond to mechanical overload included the considerably lower expression of the local splice variant mechano growth factor, and the failure to up-regulate IGF-1 receptor and MyoD mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566187     DOI: 10.1016/s0014-5793(01)02825-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  57 in total

1.  Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice.

Authors:  Mahendra D Mavalli; Douglas J DiGirolamo; Yong Fan; Ryan C Riddle; Kenneth S Campbell; Thomas van Groen; Stuart J Frank; Mark A Sperling; Karyn A Esser; Marcas M Bamman; Thomas L Clemens
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats.

Authors:  Akihiko Yamaguchi; Takahiko Fujikawa; Seita Shimada; Isao Kanbayashi; Masaru Tateoka; Hideaki Soya; Hidekatsu Takeda; Isao Morita; Kunio Matsubara; Toshihiro Hirai
Journal:  Pflugers Arch       Date:  2006-08-29       Impact factor: 3.657

3.  Research on mechano growth factor: its potential for optimising physical training as well as misuse in doping.

Authors:  G Goldspink
Journal:  Br J Sports Med       Date:  2005-11       Impact factor: 13.800

4.  Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice.

Authors:  David W Hammers; Ronald W Matheny; Christian Sell; Martin L Adamo; Thomas J Walters; J Scot Estep; Roger P Farrar
Journal:  Exp Gerontol       Date:  2010-11-18       Impact factor: 4.032

Review 5.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

6.  Expression of specific IGFBPs is associated with those of the proliferating and differentiating markers in regenerating rat plantaris muscle.

Authors:  Akihiko Yamaguchi; Kunihiro Sakuma; Takahiko Fujikawa; Isao Morita
Journal:  J Physiol Sci       Date:  2012-08-15       Impact factor: 2.781

7.  Blunted hypertrophic response in aged skeletal muscle is associated with decreased ribosome biogenesis.

Authors:  Tyler J Kirby; Jonah D Lee; Jonathan H England; Thomas Chaillou; Karyn A Esser; John J McCarthy
Journal:  J Appl Physiol (1985)       Date:  2015-06-05

8.  Functional deficits and insulin-like growth factor-I gene expression following tourniquet-induced injury of skeletal muscle in young and old rats.

Authors:  David W Hammers; Edward K Merritt; Ronald W Matheny; Wayne Matheny; Martin L Adamo; Thomas J Walters; J Scot Estep; Roger P Farrar
Journal:  J Appl Physiol (1985)       Date:  2008-07-31

9.  Insulin-like growth factor-1 prevents age-related decrease in specific force and intracellular Ca2+ in single intact muscle fibres from transgenic mice.

Authors:  Estela Gonzalez; María Laura Messi; Zhenlin Zheng; Osvaldo Delbono
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

Review 10.  Oxidative stress, molecular inflammation and sarcopenia.

Authors:  Si-Jin Meng; Long-Jiang Yu
Journal:  Int J Mol Sci       Date:  2010-04-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.